US Patent Issued to Spogen Biotech on Aug. 19 for "Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria" (Missouri Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,729, issued on Aug. 19, was assigned to Spogen Biotech Inc. (St. Louis).

"Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria" was invented by Brian Thompson (Creve Coeur, Mo.) and Ashley Siegel (St. Louis).

According to the abstract* released by the U.S. Patent & Trademark Office: "Fusion proteins containing a targeting sequence, an exosporium protein, or an exosporium protein fragment that targets the fusion protein to the exosporium of a Bacillus cereus family member are provided. Recombinant Bacillus cereus family members expressing such fusion proteins are also provided. Genetically inactivated Bacillus cereus family members and recombinant Baci...